Free Trial

Hepion Pharmaceuticals (HEPA) Short Interest Ratio & Short Volume

Hepion Pharmaceuticals logo
$0.08 0.00 (-5.43%)
As of 05/23/2025 03:54 PM Eastern

Hepion Pharmaceuticals Short Interest Data

Hepion Pharmaceuticals (HEPA) has a short interest of 448,200 shares, representing 4.12% of the float (the number of shares available for trading by the public). This marks a -30.77% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 1.30 million shares to cover all short positions.

Current Short Interest
448,200 shares
Previous Short Interest
647,400 shares
Change Vs. Previous Month
-30.77%
Dollar Volume Sold Short
$129,709.08
Short Interest Ratio
0.1 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
10,975,000 shares
Float Size
10,880,000 shares
Short Percent of Float
4.12%
Today's Trading Volume
148,859 shares
Average Trading Volume
1,295,457 shares
Today's Volume Vs. Average
11%
Short Selling Hepion Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HEPA Short Interest Over Time

HEPA Days to Cover Over Time

HEPA Percentage of Float Shorted Over Time

Hepion Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2025448,200 shares $129,709.08 -30.8%4.1%0.1 $0.29
4/15/2025647,400 shares $226,590.00 +224.0%5.9%0.2 $0.35
3/31/2025199,800 shares $85,894.02 +25.2%26.1%0.1 $0.43
3/15/2025159,600 shares $183,540.00 -96.2%14.9%0.2 $1.15
2/28/20254,160,000 shares $524,160.00 -12.4%39.4%0.2 $0.13
2/15/20254,750,000 shares $869,725.00 +75.3%44.9%0.3 $0.18
1/31/20252,710,000 shares $486,445.00 +1,180.7%25.5%0.2 $0.18
1/15/2025211,600 shares $90,501.32 +774.4%3.0%0 $0.43
12/31/202424,200 shares $11,376.42 -44.8%0.4%0.4 $0.47
12/15/202443,800 shares $25,842.00 -7.2%0.6%1 $0.59
11/30/202447,200 shares $31,529.60 -26.6%0.7%1.1 $0.67
11/15/202464,300 shares $43,724.00 -2.1%0.9%1.6 $0.68
10/31/202465,700 shares $42,639.30 +247.6%1.1%1.5 $0.65
10/15/202418,900 shares $10,757.88 -24.7%0.3%0.4 $0.57
9/30/202425,100 shares $16,817.00 -59.9%0.4%0.2 $0.67
9/15/202462,600 shares $46,324.00 -17.3%1.1%0.4 $0.74
8/31/202475,700 shares $63,436.60 -6.8%1.3%0.5 $0.84
8/15/202481,200 shares $54,785.64 -29.5%1.4%0.5 $0.67
7/31/2024115,200 shares $90,178.56 +852.1%2.0%0.7 $0.78
7/15/202412,100 shares $12,826.00 -50.4%0.2%0.1 $1.06
6/30/202424,400 shares $24,890.44 +58.4%0.5%0.7 $1.02
6/15/202415,400 shares $17,078.60 -40.1%0.3%0.4 $1.11
5/31/202425,700 shares $32,382.00 -21.7%0.5%0.6 $1.26
5/15/202432,800 shares $38,048.00 -48.7%0.6%0.7 $1.16
4/30/202463,900 shares $87,223.50 -0.2%1.2%0.9 $1.37
4/15/202464,000 shares $139,520.00 +1.9%1.2%0.8 $2.18
3/31/202462,800 shares $156,372.00 +11.0%1.5%0.8 $2.49
3/15/202456,600 shares $127,916.00 -19.6%1.3%0.7 $2.26
2/29/202470,400 shares $209,088.00 -11.0%1.6%0.8 $2.97
2/15/202479,100 shares $211,988.00 +18.2%1.9%0.9 $2.68
1/31/202466,900 shares $127,110.00 -17.7%1.6%0.9 $1.90
1/15/202481,300 shares $223,575.00 -18.0%1.9%1.2 $2.75
12/31/202399,200 shares $321,408.00 -18.5%2.3%1.5 $3.24
12/15/2023121,700 shares $484,366.00 -61.6%2.8%1.9 $3.98
11/30/2023317,200 shares $1.02 million -4.4%7.4%5.7 $3.22
11/15/2023331,700 shares $959,011.04 +15.0%7.8%6.8 $2.89
10/31/2023288,500 shares $1.35 million -22.8%6.9%8.8 $4.67
10/15/2023373,700 shares $1.72 million -11.4%9.9%12.3 $4.61
9/30/2023421,900 shares $2.11 million +10.5%11.2%15.7 $4.99
9/15/2023381,700 shares $2.00 million +24.9%10.1%13.3 $5.25
$19 for a FULL YEAR of stock picks?! (Ad)

Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.

Watch the exclusive AI investor briefing >>>
8/31/2023305,700 shares $2.28 million +3.1%8.0%8.9 $7.45
8/15/2023296,600 shares $2.07 million -8.9%7.7%0.8 $6.99
7/31/2023325,700 shares $2.59 million +2.4%8.6%0.9 $7.95
7/15/2023318,000 shares $3.18 million -1.8%8.4%0.9 $9.99
6/30/2023323,800 shares $3.40 million -11.1%8.5%0.9 $10.50
6/15/2023364,100 shares $4.21 million +52.9%9.6%1 $11.57
5/31/2023238,200 shares $2.29 million +237.4%6.3%0.7 $9.60
5/15/202370,600 shares $473,020.00 +105.8%1.9%0.2 $6.70
4/30/2023685,900 shares $477,043.45 +6.3%0.9%3.8 $0.70
4/15/2023645,100 shares $490,276.00 -7.7%0.9%2.6 $0.76
3/31/2023698,800 shares $542,618.20 -2.8%0.9%1 $0.78
3/15/2023719,000 shares $540,328.50 +0.3%0.9%1 $0.75
2/28/2023716,600 shares $625,950.10 -13.8%0.9%1 $0.87
2/15/2023831,100 shares $706,435.00 -8.3%1.1%1.1 $0.85
1/31/2023905,900 shares $661,125.82 -49.1%1.2%1.2 $0.73
1/15/20231,780,000 shares $1.65 million +221.0%2.3%2.5 $0.93
12/30/2022554,600 shares $166,546.38 +0.3%0.7%1.7 $0.30
12/15/2022553,100 shares $182,523.00 +3.2%0.7%2.6 $0.33
11/30/2022535,800 shares $195,674.16 -2.5%0.7%2.9 $0.37
11/15/2022549,700 shares $241,813.03 -5.4%0.7%3.2 $0.44
10/31/2022581,200 shares $309,489.00 -9.9%0.8%3.9 $0.53
10/15/2022645,200 shares $296,727.48 -6.6%0.9%4.7 $0.46
9/30/2022691,000 shares $349,093.20 -6.3%0.9%4.9 $0.51
9/15/2022737,500 shares $441,025.00 -9.5%1.0%5.1 $0.60
8/31/2022814,700 shares $556,195.69 -15.3%1.1%5.2 $0.68
8/15/2022961,600 shares $712,834.08 -12.6%1.3%5.9 $0.74
7/31/20221,100,000 shares $594,000.00 +21.6%1.5%5.6 $0.54
7/15/2022904,700 shares $544,086.58 -7.7%1.2%4.6 $0.60
6/30/2022980,300 shares $561,221.75 -7.5%1.3%4.9 $0.57
6/15/20221,060,000 shares $717,620.00 -7.0%1.4%4.6 $0.68
5/31/20221,140,000 shares $889,314.00 -7.3%1.5%4.8 $0.78
5/15/20221,230,000 shares $852,390.00 -14.6%1.6%4.1 $0.69
4/30/20221,440,000 shares $1.33 million -9.4%1.9%4.6 $0.93
4/15/20221,590,000 shares $1.67 million -7.0%2.1%4.3 $1.05
3/31/20221,710,000 shares $2.21 million +8.2%2.3%4.2 $1.29
3/15/20221,580,000 shares $1.69 million -0.6%2.1%3 $1.07
2/28/20221,590,000 shares $1.75 million -5.4%2.1%2.8 $1.10
2/15/20221,680,000 shares $1.71 million -10.2%2.2%2.7 $1.02
1/31/20221,870,000 shares $1.83 million +2.2%2.5%2.6 $0.98
1/15/20221,830,000 shares $2.12 million -6.2%2.4%2.4 $1.16
12/31/20211,950,000 shares $2.22 million +2.6%2.6%2.6 $1.14
12/15/20211,900,000 shares $2.30 million +15.2%2.5%2.4 $1.21
11/30/20211,650,000 shares $2.05 million -7.8%2.2%1.5 $1.24
11/15/20211,790,000 shares $2.63 million -1.1%2.4%1.5 $1.47
10/29/20211,810,000 shares $2.59 million -11.3%2.4%1.5 $1.43
10/15/20212,040,000 shares $3.10 million +17.9%2.7%1.6 $1.52
9/30/20211,730,000 shares $2.65 million -40.1%2.3%1.1 $1.53
9/15/20212,890,000 shares $4.60 million +61.5%3.8%1.7 $1.59
8/31/20211,790,000 shares $2.88 million -10.5%2.4%0.9 $1.61
8/13/20212,000,000 shares $2.94 million -14.5%2.6%1.1 $1.47
$19 for a FULL YEAR of stock picks?! (Ad)

Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.

Watch the exclusive AI investor briefing >>>
7/30/20212,340,000 shares $3.60 million -2.1%3.1%1.2 $1.54
7/15/20212,390,000 shares $3.80 million +64.8%3.1%1.1 $1.59
6/30/20211,450,000 shares $2.87 million -13.7%1.9%0.7 $1.98
6/15/20211,680,000 shares $3.70 million +27.3%2.2%0.8 $2.20
5/28/20211,320,000 shares $2.24 million +6.5%1.7%0.4 $1.70
5/14/20211,240,000 shares $1.93 million -32.6%N/A0.3 $1.56
4/30/20211,840,000 shares $3.28 million -20.7%N/A0.3 $1.78
4/15/20212,320,000 shares $4.08 million -22.9%N/A0.4 $1.76
3/31/20213,010,000 shares $5.36 million +57.6%N/A0.5 $1.78
3/15/20211,910,000 shares $4.66 million -26.5%N/A0.3 $2.44
2/26/20212,600,000 shares $5.10 million +273.3%N/A0.5 $1.96
2/12/2021696,500 shares $1.98 million +159.7%N/A0.1 $2.84
1/29/2021268,200 shares $549,810.00 -6.8%N/A0.1 $2.05
1/15/2021287,600 shares $672,984.00 -58.0%N/A0.1 $2.34
12/31/2020685,100 shares $1.61 million +236.7%N/A0.4 $2.35
12/15/2020203,500 shares $386,650.00 -43.4%N/A0.1 $1.90
11/30/2020359,500 shares $607,555.00 +9.7%N/A0.4 $1.69
11/15/2020327,600 shares $956,592.00 +51.3%N/A1.5 $2.92
10/30/2020216,600 shares $723,444.00 -39.7%N/A0.9 $3.34
10/15/2020359,400 shares $1.25 million -26.7%N/A0.9 $3.47
9/30/2020490,500 shares $1.53 million +4.1%N/A0.9 $3.11
9/15/2020471,000 shares $1.53 million -22.7%N/A0.3 $3.25

HEPA Short Interest - Frequently Asked Questions

What is Hepion Pharmaceuticals' current short interest?

Short interest is the volume of Hepion Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 448,200 shares of HEPA short. 4.12% of Hepion Pharmaceuticals' shares are currently sold short. Learn More on Hepion Pharmaceuticals' current short interest.

What is a good short interest percentage for Hepion Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.12% of Hepion Pharmaceuticals' floating shares are currently sold short.

Is Hepion Pharmaceuticals' short interest increasing or decreasing?

Hepion Pharmaceuticals saw a drop in short interest in April. As of April 30th, there was short interest totaling 448,200 shares, a drop of 30.8% from the previous total of 647,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Hepion Pharmaceuticals' float size?

Hepion Pharmaceuticals currently has issued a total of 10,975,000 shares. Some of Hepion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hepion Pharmaceuticals currently has a public float of 10,880,000 shares.

How does Hepion Pharmaceuticals' short interest compare to its competitors?

4.12% of Hepion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Hepion Pharmaceuticals: Sonnet BioTherapeutics Holdings, Inc. (4.10%), Galecto, Inc. (6.11%), Titan Pharmaceuticals, Inc. (1.34%), Sunshine Biopharma, Inc. (12.24%), Jaguar Health, Inc. (20.36%), PainReform Ltd. (7.27%), Mustang Bio, Inc. (10.17%), Tharimmune, Inc. (5.32%), CNS Pharmaceuticals, Inc. (21.57%), Kazia Therapeutics Limited (1.91%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Hepion Pharmaceuticals stock?

Short selling HEPA is an investing strategy that aims to generate trading profit from Hepion Pharmaceuticals as its price is falling. HEPA shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Hepion Pharmaceuticals?

A short squeeze for Hepion Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HEPA, which in turn drives the price of the stock up even further.

How often is Hepion Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HEPA, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:HEPA) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners